• Home
  • About
  • Contact Us
  • COVID-19 and Infectious Diseases
  • Health and Wellness
  • Specialty Pharma
  • Technology
  • For Employers
  • Resources
  • Company Blogs
  • News

Preserve: Innovating in Alzheimer's Disease

and Senile Dementia

6 million Americans are affected by Alzheimer's Disease or Senile Dementia (13% > 65 years old)A ketogenic diet (low carb), resulting in ketosis, significantly slowsearly-onset of Alzheimer's Disease and Senile Dementia.
Long-Term Care facilities can now implement an Alzheimer's and Senile Dementia Prevention and Control Program designed to increase the quality of life of patients by slowing the progression of these diseases.The program consists of specially designed low carb diets and mHealthTestsTM that measure ketosis to ensure compliance. The digital app is key for monitoring and informing caregivers and loved ones.

Product Information PDF

Akers Nanotechnology values your privacy online. Our website uses cookies to enhance your user experience. Read about how we use cookies.

Your Cookie Settings

We use cookies to enable essential functionality on our website, and analyze website traffic. Read about how we use cookies.

Cookie Categories
Essential

These cookies are strictly necessary to provide you with services available through our websites. You cannot refuse these cookies without impacting how our websites function. You can block or delete them by changing your browser settings, as described under the heading "Managing cookies" in the Privacy and Cookies Policy.

Analytics

These cookies collect information that is used in aggregate form to help us understand how our websites are being used or how effective our marketing campaigns are.